Price $1.54 |
Market Cap
57.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
3.9
|
P/B
1.52
|
P/S
1.27
|
Dividend %
-
|
|
P/CF
2.9
|
P/FCF
3.1
|
Op. Cash Flow
21.6K
|
FCF
0.8
|
|
Op. Margin
40.20%
|
Net Margin
41.20%
|
ROE
54.40%
|
ROI
38.80%
|
|
ROA
49.00%
|
EPS Growth
174.40%
|
Current Ratio
17.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.05 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.54 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.10 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $2.24 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.14 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
